Abstract
Globally, esophageal cancer (EC) ranks 7th in cancer incidence and 6th in cancer-related mortality. A 5-year survival of 3% for stage IV patients reflects poor prognosis and places significant burden on patient lives. A systematic literature review (SLR) was conducted to characterize the humanistic burden using health-related quality of life (HRQoL) outcomes and health utilities in advanced/metastatic esophageal cancer (EC) patients and evaluate evidence gaps.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
